Organoclick AB (ORGC) — Capital Reinvestment Ratio

Latest as of December 2025: 0.02x

Organoclick AB (ORGC) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (Skr2.97 Million) in capital expenditures (Skr51.00K). See Organoclick AB (ORGC) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

Skr2.97 Million
SEK

Capital Expenditures

Skr51.00K
SEK

Data as of

Dec 2025
Most recent filing

Organoclick AB Capital Reinvestment Ratio (2013–2024)

This chart tracks Organoclick AB's Capital Reinvestment Ratio across 4 annual periods. Check Organoclick AB (ORGC) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Organoclick AB (2013–2024)

Year-by-year Capital Reinvestment Ratio for Organoclick AB from 2013 to 2024. For live market cap and broader valuation context, see market value of Organoclick AB.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2024 2.53x Skr3.60 Million Skr9.11 Million ▼ -84.3%
2023 16.15x Skr533.00K Skr8.61 Million ▲ +355.6%
2020 3.55x Skr5.47 Million Skr19.40 Million ▲ +1.4%
2013 3.50x Skr313.54K Skr1.10 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow